Tannic Acid Modified Silver Nanoparticles Show Antiviral Activity in Herpes Simplex Virus Type 2 Infection

Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry

(2013) Liang-Tzung Lin et al.   BMC MICROBIOLOGY

Fas/FasL pathway participates in resolution of mucosal inflammatory response early during HSV-2 infection

(2013) Malgorzata Krzyzowska et al.   IMMUNOBIOLOGY

Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo

(2013) Dongxi Xiang et al.   International Journal of Nanomedicine

Silver Nanoparticles Inhibit Vaccinia virus Infection by Preventing Viral Entry Through a Macropinocytosis-Dependent Mechanism

(2013) John C. Trefry et al.   Journal of Biomedical Nanotechnology

Comparative study of respiratory tract immune toxicity induced by three sterilisation nanoparticles: Silver, zinc oxide and titanium dioxide

(2013) Huanliang Liu et al.   JOURNAL OF HAZARDOUS MATERIALS

Mast Cells Play a Key Role in Host Defense against Herpes Simplex Virus Infection through TNF-α and IL-6 Production

(2013) Rui Aoki et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles

(2012) Renata de Lima et al.   JOURNAL OF APPLIED TOXICOLOGY

Hydrolyzable Tannins (Chebulagic Acid and Punicalagin) Target Viral Glycoprotein-Glycosaminoglycan Interactions To Inhibit Herpes Simplex Virus 1 Entry and Cell-to-Cell Spread

(2011) L.-T. Lin et al.   JOURNAL OF VIROLOGY

Role of Fas/FasL in regulation of inflammation in vaginal tissue during HSV-2 infection

(2011) M Krzyzowska et al.   Cell Death & Disease

Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management

(2010) Jocelyne Piret et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity

(2010) Helinor J. Johnston et al.   CRITICAL REVIEWS IN TOXICOLOGY

Impact of silver nanoparticles on human cells: Effect of particle size

(2010) Wei Liu et al.   Nanotoxicology

Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue

(2010) N. Iijima et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Inhibition of HSV-1 Attachment, Entry, and Cell-to-Cell Spread by Functionalized Multivalent Gold Nanoparticles

(2010) Dana Baram-Pinto et al.   Small

Mode of antiviral action of silver nanoparticles against HIV-1

(2010) Humberto H Lara et al.   JOURNAL OF NANOBIOTECHNOLOGY

PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture

(2010) Humberto H Lara et al.   JOURNAL OF NANOBIOTECHNOLOGY

Inhibition of Herpes Simplex Virus Type 1 Infection by Silver Nanoparticles Capped with Mercaptoethane Sulfonate

(2009) Dana Baram-Pinto et al.   BIOCONJUGATE CHEMISTRY

Further Evidence of the Anti-inflammatory Effects of Silver Nanoparticles

(2009) Kenneth K. Y. Wong et al.   ChemMedChem

Evaluation of Silver Nanoparticle Toxicity in Skin in Vivo and Keratinocytes in Vitro

(2009) Meghan E. Samberg et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry

(2009) Jihan Akhtar et al.   FEBS Journal

CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help

(2009) Yusuke Nakanishi et al.   NATURE

Cytotoxicity and Immunological Response of Gold and Silver Nanoparticles of Different Sizes

(2009) Hung-Jen Yen et al.   Small

Herpes simplex virus type 2 and syphilis infections with HIV: an evolving synergy in transmission and prevention

(2009) Aaron AR Tobian et al.   Current Opinion in HIV and AIDS

Coordination of Early Protective Immunity to Viral Infection by Regulatory T Cells

(2008) J. M. Lund et al.   SCIENCE